Back to ressources
XenTech patient-derived xenograft (PDX) panels: a clinically relevant platform for drug efficacy, target validation and predictive biomarker discovery studies
Pascal Leuraud, Stefano Cairo, Olivier Deas, Marie-France Poupon, Jean-Gabriel Judde.
World Pharma Congress – 2014
Read the publication
Discover
CTC-derived eXplants (CDX) offer systems for mechanistic investigation of CTC metastatic potency and may provide rationale for biology-driven therapeutics.
Discover
Discover
A preclinical platform of mouse-transplanted human pediatric liver tumors to evaluate the efficacy of conventional and innovative anticancer therapy
Discover
Discover
